Skip to main content
Clinical Trials/ITMCTR1900002478
ITMCTR1900002478
Recruiting
未知

Standardization clinical research and mechanism discussion of of natural moxibustion acupoint application for Bronchial Asthma

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Bronchial Asthma
Sponsor
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1 Patients who are diagnosed as chronic duration and clinical remission of bronchial asthma in Western medicine;
  • 2 Patients who are diagnosed with Chinese medicine asthma lung and kidney qi deficiency syndrome;
  • 3 The severity of the disease is classified as mildly persistent or moderately persistent;
  • 4 Aged 18 to 75 years, both men and women;
  • 5 Those who voluntarily receive the drug and sign the informed consent form (the informed consent process complies with the GCP requirements).

Exclusion Criteria

  • 1 other diseases with airflow obstruction, such as chronic obstructive pulmonary disease, bronchiectasis, pulmonary tuberculosis, diffuse panbronchiolitis and other patients;
  • 2 patients with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, upper extremity ankle amputation and hematopoietic dysfunction;
  • 3 mental patients and those who cannot be treated for other reasons;
  • 4 pregnant or lactating women;
  • 5 It is known that those who are allergic to the test ingredients and the skin of the treatment site have blistering, sputum, damage and fever.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
The clinical standardization study on the treatment of spleen deficiency syndrome after repeated respiratory tract infection by the method of cultivating earth to generate goldSpleen deficiency syndrome after recurrent respiratory tract infection in children
ITMCTR2100004923Children's Hospital of Shanghai
Not yet recruiting
Phase 1
Research on standardization and clinical evaluation of Traditional Chinese Medicine press needle combined with auricular point pressing to prevent and control myopia in children and adolescents
ITMCTR2100005080Eye Hospital China Academy of Chinese Medical Science
Not yet recruiting
Not Applicable
Clinical study of standardized Ashwagandha in healthy male volunteers
CTRI/2023/04/051632Pharmanza Herbal Pvt. Ltd.
Active, not recruiting
Not Applicable
STANDARD-Study -- Standardized Treatment and Diagnostic Approach to Reduce Disease burden in the early post-operative phase in children with congenital heart defectsQ20-Q28Congenital malformations of the circulatory system
DRKS00025430niversitätsklinikum des Saarlandes74
Active, not recruiting
Not Applicable
Standardized clinical trial on the application of Levodopa (LD) / Carbidopa (CD) to patients with Parkinson disease vs LD / CD and Entacapon (EN) vs LD / CD and Tolcapon (TO) concerning the parameters motor function, pharmacokinetics of LD, plasma level of homocystein and serum level of cortisol.Male and female patients with Parkinson´s disease meeting UKPDS criteriaMedDRA version: 12.1Level: LLTClassification code 10013113Term: Disease Parkinson's
EUCTR2009-017416-33-DEClinical research lab for neurodegeneration, Dept. of Neurology, St. Josef-Hospital, Ruhr-University